Targeted protein degradation: current and future challenges
Traditional approaches in the development of small-molecule drugs typically aim to inhibit
the biochemical activity of functional protein domains. In contrast, targeted protein …
the biochemical activity of functional protein domains. In contrast, targeted protein …
[HTML][HTML] Targeted protein degradation: current and future challenges
A Hanzl, GE Winter - Current opinion in chemical biology, 2020 - ncbi.nlm.nih.gov
Traditional approaches in the development of small-molecule drugs typically aim to inhibit
the biochemical activity of functional protein domains. In contrast, targeted protein …
the biochemical activity of functional protein domains. In contrast, targeted protein …
Targeted protein degradation: current and future challenges
A Hanzl, GE Winter - Current opinion in chemical biology, 2020 - pubmed.ncbi.nlm.nih.gov
Traditional approaches in the development of small-molecule drugs typically aim to inhibit
the biochemical activity of functional protein domains. In contrast, targeted protein …
the biochemical activity of functional protein domains. In contrast, targeted protein …
Targeted protein degradation: current and future challenges.
A Hanzl, GE Winter - Current Opinion in Chemical Biology, 2020 - europepmc.org
Traditional approaches in the development of small-molecule drugs typically aim to inhibit
the biochemical activity of functional protein domains. In contrast, targeted protein …
the biochemical activity of functional protein domains. In contrast, targeted protein …
Targeted protein degradation: current and future challenges.
A Hanzl, GE Winter - Current Opinion in Chemical Biology, 2020 - europepmc.org
Traditional approaches in the development of small-molecule drugs typically aim to inhibit
the biochemical activity of functional protein domains. In contrast, targeted protein …
the biochemical activity of functional protein domains. In contrast, targeted protein …